Methyl 1-(2-methylpropyl)-2-spiro[5H-indolo[1,2-a]quinoxaline-6,1'-cyclohexane]-1-ylbenzimidazole-5-carboxylate
C33H34N4O2 — CID 102293325
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 1-(2-methylpropyl)-2-spiro[5H-indolo[1,2-a]quinoxaline-6,1'-cyclohexane]-1-ylbenzimidazole-5-carboxylate
Methyl 1-(2-methylpropyl)-2-spiro[5H-indolo[1,2-a]quinoxaline-6,1'-cyclohexane]-1-ylbenzimidazole-5-carboxylate (PubChem CID 102293325) has the molecular formula C33H34N4O2 and a molecular weight of 518.66 g/mol. Its IUPAC name is methyl 1-(2-methylpropyl)-2-spiro[5H-indolo[1,2-a]quinoxaline-6,1'-cyclohexane]-1-ylbenzimidazole-5-carboxylate.
Molecular Properties
| Compound Name | Methyl 1-(2-methylpropyl)-2-spiro[5H-indolo[1,2-a]quinoxaline-6,1'-cyclohexane]-1-ylbenzimidazole-5-carboxylate |
|---|---|
| PubChem CID | 102293325 |
| Molecular Formula | C33H34N4O2 |
| Molecular Weight | 518.66 g/mol |
| Exact Mass | 518.27 |
| IUPAC Name | methyl 1-(2-methylpropyl)-2-spiro[5H-indolo[1,2-a]quinoxaline-6,1'-cyclohexane]-1-ylbenzimidazole-5-carboxylate |
| SMILES | COC(=O)c1ccc2c(c1)nc(-c1cccc3c1-n1c(cc4ccccc41)C1(CCCCC1)N3)n2CC(C)C |
| InChI | InChI=1S/C33H34N4O2/c1-21(2)20-36-28-15-14-23(32(38)39-3)18-26(28)34-31(36)24-11-9-12-25-30(24)37-27-13-6-5-10-22(27)19-29(37)33(35-25)16-7-4-8-17-33/h5-6,9-15,18-19,21,35H,4,7-8,16-17,20H2,1-3H3 |
| InChIKey | BUDXHCBDMQGMKP-UHFFFAOYSA-N |
| XLogP | 7.67 |
| TPSA | 61.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.66 |
| LogP ≤ 5 | 7.67 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 102293325 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.